Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
EUDA Health Holdings Ltd Create: Alert

All | News | Filings
Date FiledTypeDescription
08/14/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2023 Commission File Number: 001-40678 EUDA Health Holdings Limited 1 Pemimpin Drive #12-07 One Pemimpin Singapore 576151 Registrant’ s telephone number, including area code: +65 6268 6821 Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F ☒ Form 40-F ☐ Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101: ☐ Note: Regulation S-T Rule 101 only permits the submission in paper of a Form 6-K if submitted solely to provide an a..."
08/04/2023 F-1/A Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
08/02/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2023 Commission File Number: 001-40678 EUDA Health Holdings Limited 1 Pemimpin Drive #12-07 One Pemimpin Singapore 576151 Registrant’ s telephone number, including area code: +65 6268 6821 Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F ☒ Form 40-F ☐ Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101: ☐ Note: Regulation S-T Rule 101 only permits the submission in paper of a Form 6-K if submitted solely to provide an att..."
07/31/2023 10-Q Quarterly Report for the period ended March 31, 2023
07/03/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2023 Commission File Number: 001-40678 EUDA Health Holdings Limited 1 Pemimpin Drive #12-07 One Pemimpin Singapore 576151 Registrant’ s telephone number, including area code: +65 6268 6821 Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F ☒ Form 40-F ☐ Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101: ☐ Note: Regulation S-T Rule 101 only permits the submission in paper of a Form 6-K if submitted solely to provide an att..."
06/28/2023 10-K Annual Report for the period ended December 31, 2022
06/09/2023 8-K Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Unregistered Sales of Equity Secu...
05/31/2023 D Form D - Notice of Exempt Offering of Securities:
05/26/2023 SC 13D/A Tan Meng Dong reports a 27.7% stake in EUDA Health Holdings Limited
05/26/2023 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits ...
Docs: "Registration Rights Agreement"
05/24/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
05/19/2023 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
05/19/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and...
Docs: "EUDA Health Holdings Limited Announces Receipt of Nasdaq Listing Delinquency Letter Singapore, May 19, 2023 – EUDA Health Holdings Limited , a Singapore-based health technology company that operates a first-of-its-kind Southeast Asian digital healthcare ecosystem, announced today that it received a delinquency notification letter from the Listing Qualifications Staff of the Nasdaq Stock Market LLC on May 18, 2023 due to the Company’ s non-compliance with Nasdaq Listing Rule 5250 as a result of the Company’ s failure to timely file its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2023 . Nasdaq Listing Rule 5250 requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission . As reported on April 10, 2023, ..."
05/19/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
05/11/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
03/31/2023 NT 10-K Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
03/15/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
03/07/2023 8-K Resignation/termination of a director
03/01/2023 8-K Quarterly results
02/14/2023 SC 13G/A Ayrton Capital LLC reports a 4.9% stake in EUDA HEALTH HOLDINGS LIMITED
02/07/2023 SC 13G/A Hudson Bay Capital Management LP reports a 4.8% stake in EUDA Health Holdings Limited
01/31/2023 8-K Resignation/termination of a director
12/09/2022 SC 13G/A Karpus Management, Inc. reports a
11/25/2022 SC 13D Tan Meng Dong reports a 26% stake in EUDA Health Holdings Limited
11/25/2022 SC 13D Watermark Developments Ltd reports a 47.8% stake in EUDA Health Holdings Limited
11/23/2022 8-K Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failur...
Docs: "Agreement”) is made as of November 17, 2022, by and between EUDA Health Holdings Limited, a British Virgin Islands business company , and a member of the board of directors and/or officer of the Company, as applicable . This Agreement supersedes and replaces any and all previous Agreements between the Company and Indemnitee covering the subject matter of this Agreement.",
"Subsidiaries of EUDA Health Holdings Limited",
"Euda Health Limited and Subsidiaries Index to Unaudited Condensed Consolidated Financial Statements Condensed Consolidated Balance Sheets as of September 30, 2022 and December 31, 2021 2 Unaudited Condensed Consolidated Statements of Operations and Comprehensive Income for the Nine Months Ended September 30, 2022 and 2021 3 Unaudited Condensed Consolidated Statements of Change in Shareholders’ Equity for the Nine Months Ended September 30, 2022 and 2021 4 Unaudited Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2022 and 2021 5 Notes to Unaudited Condensed Consolidated Financial Statements 6 1 EUDA HEALTH LIMITED AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS September 30, December 31, 2022 2021 ASSETS CURRENT ASSETS Cash $ 341,100 $ 189,996...",
"MANAGEMENT’ S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS OF EUDA",
"UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION The following unaudited pro forma condensed combined financial information present the combination of the financial information of 8i and EUDA adjusted to give effect to the Business Combination. The following unaudited pro forma condensed combined financial information has been prepared in accordance with Article 11 of Regulation S-X. The unaudited pro forma condensed combined balance sheet as of September 30, 2022 combines the historical condensed consolidated balance sheet of 8i as of October 31, 2022, the historical balance sheet of EUDA as of September 30, 2022, respectively, on a pro forma basis as if the Business Combination had been consummated on September 30, 2022. The unaudited pro forma condensed combined statement of...",
"8i Acquisition 2 Corp. and EUDA Health Limited Complete Business Combination"
11/23/2022 SC 13G Ayrton Capital LLC reports a 5.1% stake in EUDA HEALTH HOLDINGS LIMITED
11/22/2022 10-Q Quarterly Report for the period ended October 31, 2022
11/17/2022 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
11/17/2022 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
11/07/2022 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Agreement",
"Wavier Agreement"
11/07/2022 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
10/13/2022 DEFM14A Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
10/06/2022 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy